Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Patient X: A 67-year-old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X-r...

Full description

Bibliographic Details
Main Authors: O'Day, Elizabeth, Hosta-Rigau, Leticia, Oyarzún, Diego A., Okano, Hideyuki, de Lorenzo, Víctor, von Kameke, Conrad, Alsafar, Habiba, Cao, Cong, Chen, Guo-Qiang, Ji, Weizhi, Roberts, Richard J., Ronaghi, Mostafa, Yeung, Karen, Zhang, Feng, Lee, Sang Yup
Other Authors: McGovern Institute for Brain Research at MIT
Format: Article
Language:English
Published: Wiley 2020
Online Access:https://hdl.handle.net/1721.1/126515

Internet

https://hdl.handle.net/1721.1/126515

Similar Items